Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 37 | 2023 | 68 | 11.580 |
Why?
|
| Obesity, Morbid | 36 | 2023 | 97 | 10.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2022 | 148 | 5.060 |
Why?
|
| Weight Loss | 20 | 2022 | 121 | 4.080 |
Why?
|
| Bariatric Surgery | 14 | 2023 | 51 | 3.980 |
Why?
|
| Laparoscopy | 29 | 2022 | 184 | 3.550 |
Why?
|
| Postoperative Complications | 13 | 2023 | 811 | 1.940 |
Why?
|
| Insulin Resistance | 6 | 2018 | 48 | 1.810 |
Why?
|
| Obesity | 8 | 2022 | 289 | 1.790 |
Why?
|
| Middle Aged | 52 | 2022 | 7911 | 1.510 |
Why?
|
| Gastroesophageal Reflux | 12 | 2012 | 27 | 1.500 |
Why?
|
| Gastrectomy | 7 | 2023 | 28 | 1.320 |
Why?
|
| Humans | 79 | 2023 | 22958 | 1.320 |
Why?
|
| Female | 56 | 2022 | 12958 | 1.310 |
Why?
|
| Adult | 41 | 2022 | 6927 | 1.290 |
Why?
|
| Male | 52 | 2022 | 12466 | 1.250 |
Why?
|
| Adipose Tissue | 4 | 2018 | 73 | 1.230 |
Why?
|
| Fundoplication | 10 | 2012 | 21 | 1.190 |
Why?
|
| Prospective Studies | 21 | 2022 | 1493 | 1.150 |
Why?
|
| Body Mass Index | 9 | 2020 | 378 | 1.100 |
Why?
|
| Gastroplasty | 6 | 2019 | 27 | 1.030 |
Why?
|
| Insulin | 4 | 2016 | 77 | 1.030 |
Why?
|
| Esophageal Achalasia | 7 | 2015 | 17 | 0.950 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 120 | 0.860 |
Why?
|
| Treatment Outcome | 22 | 2022 | 2941 | 0.860 |
Why?
|
| Bibliometrics | 2 | 2021 | 22 | 0.820 |
Why?
|
| Quality of Life | 7 | 2016 | 559 | 0.820 |
Why?
|
| Follow-Up Studies | 15 | 2022 | 1412 | 0.810 |
Why?
|
| General Surgery | 2 | 2021 | 50 | 0.790 |
Why?
|
| Caloric Restriction | 2 | 2014 | 11 | 0.790 |
Why?
|
| Biomarkers | 3 | 2020 | 476 | 0.780 |
Why?
|
| Digestive System Surgical Procedures | 6 | 2015 | 23 | 0.740 |
Why?
|
| Adiponectin | 2 | 2012 | 10 | 0.730 |
Why?
|
| Omentum | 2 | 2012 | 7 | 0.730 |
Why?
|
| Bone Density | 2 | 2020 | 146 | 0.720 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 25 | 0.690 |
Why?
|
| Case-Control Studies | 9 | 2019 | 481 | 0.690 |
Why?
|
| Esophagus | 3 | 2012 | 53 | 0.670 |
Why?
|
| Weight Gain | 2 | 2021 | 61 | 0.650 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 58 | 0.650 |
Why?
|
| Mental Disorders | 1 | 2022 | 134 | 0.640 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 31 | 0.630 |
Why?
|
| Osteoclasts | 1 | 2020 | 20 | 0.630 |
Why?
|
| Protein Precursors | 1 | 2019 | 17 | 0.620 |
Why?
|
| Retrospective Studies | 15 | 2023 | 2994 | 0.610 |
Why?
|
| Fractures, Bone | 1 | 2020 | 70 | 0.600 |
Why?
|
| Neoplasms | 1 | 2022 | 216 | 0.600 |
Why?
|
| Hydroxybutyrates | 1 | 2018 | 6 | 0.560 |
Why?
|
| Aged | 22 | 2022 | 7448 | 0.560 |
Why?
|
| Postprandial Period | 3 | 2016 | 7 | 0.550 |
Why?
|
| Vascular Diseases | 1 | 2016 | 34 | 0.490 |
Why?
|
| Glucagon-Like Peptide 1 | 3 | 2016 | 9 | 0.480 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 290 | 0.480 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 35 | 0.470 |
Why?
|
| Adipocytes | 2 | 2012 | 21 | 0.460 |
Why?
|
| Peptide YY | 2 | 2011 | 2 | 0.450 |
Why?
|
| Leptin | 2 | 2011 | 18 | 0.450 |
Why?
|
| Anastomosis, Roux-en-Y | 4 | 2007 | 7 | 0.430 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2013 | 5 | 0.420 |
Why?
|
| Time Factors | 6 | 2016 | 1262 | 0.410 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 55 | 0.400 |
Why?
|
| Postoperative Period | 5 | 2020 | 237 | 0.390 |
Why?
|
| Cohort Studies | 5 | 2022 | 1417 | 0.390 |
Why?
|
| Gastric Acid | 1 | 2012 | 9 | 0.390 |
Why?
|
| Nomograms | 1 | 2012 | 5 | 0.380 |
Why?
|
| Subcutaneous Fat | 1 | 2012 | 8 | 0.370 |
Why?
|
| Reoperation | 5 | 2021 | 743 | 0.370 |
Why?
|
| E2F4 Transcription Factor | 1 | 2011 | 2 | 0.360 |
Why?
|
| Appetite | 1 | 2011 | 4 | 0.360 |
Why?
|
| Cell Differentiation | 1 | 2012 | 126 | 0.360 |
Why?
|
| Blood Glucose | 4 | 2014 | 103 | 0.360 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 41 | 0.350 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 73 | 0.350 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 128 | 0.340 |
Why?
|
| Catheter Ablation | 4 | 2004 | 34 | 0.330 |
Why?
|
| Risk Factors | 8 | 2021 | 1971 | 0.290 |
Why?
|
| Adolescent | 7 | 2020 | 1881 | 0.290 |
Why?
|
| United States | 6 | 2022 | 1765 | 0.290 |
Why?
|
| Bone and Bones | 2 | 2019 | 107 | 0.280 |
Why?
|
| Body Composition | 2 | 2021 | 66 | 0.270 |
Why?
|
| Young Adult | 6 | 2020 | 1651 | 0.270 |
Why?
|
| Deglutition Disorders | 2 | 2007 | 30 | 0.270 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2007 | 1 | 0.260 |
Why?
|
| Coronary Disease | 1 | 2007 | 49 | 0.260 |
Why?
|
| Incidence | 2 | 2022 | 624 | 0.260 |
Why?
|
| Esophagectomy | 1 | 2006 | 23 | 0.240 |
Why?
|
| Laparotomy | 2 | 2021 | 17 | 0.240 |
Why?
|
| Cholecystitis | 3 | 2023 | 8 | 0.230 |
Why?
|
| Esophagoscopy | 5 | 2005 | 15 | 0.230 |
Why?
|
| Hypoglycemia | 2 | 2016 | 12 | 0.230 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2015 | 292 | 0.220 |
Why?
|
| Esophageal Neoplasms | 2 | 2005 | 50 | 0.220 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2012 | 11 | 0.210 |
Why?
|
| Prognosis | 5 | 2020 | 730 | 0.210 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 13 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 82 | 0.210 |
Why?
|
| Preoperative Period | 3 | 2019 | 65 | 0.200 |
Why?
|
| Transcription Factors | 1 | 2004 | 149 | 0.200 |
Why?
|
| Apoptosis | 1 | 2004 | 196 | 0.200 |
Why?
|
| Absorptiometry, Photon | 2 | 2014 | 86 | 0.200 |
Why?
|
| Gallstones | 1 | 2023 | 6 | 0.200 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 135 | 0.200 |
Why?
|
| Patient Readmission | 2 | 2021 | 117 | 0.200 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 228 | 0.190 |
Why?
|
| Energy Metabolism | 2 | 2021 | 43 | 0.190 |
Why?
|
| Fibronectins | 1 | 2022 | 17 | 0.180 |
Why?
|
| Remission Induction | 2 | 2016 | 89 | 0.180 |
Why?
|
| Metabolome | 1 | 2021 | 9 | 0.180 |
Why?
|
| Preoperative Care | 2 | 2016 | 107 | 0.180 |
Why?
|
| Comorbidity | 2 | 2021 | 426 | 0.180 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 92 | 0.180 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 7 | 0.170 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 190 | 0.170 |
Why?
|
| Cells, Cultured | 2 | 2012 | 469 | 0.170 |
Why?
|
| Hospital Mortality | 1 | 2021 | 129 | 0.170 |
Why?
|
| Cefoxitin | 1 | 2020 | 3 | 0.170 |
Why?
|
| Metronidazole | 1 | 2020 | 5 | 0.170 |
Why?
|
| Levofloxacin | 1 | 2020 | 3 | 0.170 |
Why?
|
| Linear Models | 2 | 2014 | 193 | 0.160 |
Why?
|
| Medicare | 1 | 2021 | 106 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 26 | 0.160 |
Why?
|
| Risk Assessment | 3 | 2014 | 548 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 760 | 0.160 |
Why?
|
| Morbidity | 1 | 2020 | 50 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 235 | 0.160 |
Why?
|
| Analysis of Variance | 2 | 2019 | 228 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 243 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2020 | 63 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 29 | 0.140 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 2 | 0.140 |
Why?
|
| Ideal Body Weight | 1 | 2017 | 3 | 0.140 |
Why?
|
| Kidney | 1 | 2018 | 142 | 0.130 |
Why?
|
| Length of Stay | 2 | 2017 | 298 | 0.130 |
Why?
|
| Patient Satisfaction | 4 | 2007 | 256 | 0.130 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 157 | 0.130 |
Why?
|
| Gene Expression | 1 | 2017 | 178 | 0.130 |
Why?
|
| Esophagogastric Junction | 3 | 2004 | 13 | 0.120 |
Why?
|
| Recurrence | 1 | 2016 | 268 | 0.120 |
Why?
|
| Surveys and Questionnaires | 4 | 2007 | 1020 | 0.110 |
Why?
|
| Mental Health | 1 | 2016 | 94 | 0.110 |
Why?
|
| Gastroscopy | 2 | 2004 | 9 | 0.110 |
Why?
|
| Gastrointestinal Hormones | 1 | 2014 | 1 | 0.110 |
Why?
|
| Amino Acids | 1 | 2014 | 18 | 0.110 |
Why?
|
| Lipids | 1 | 2014 | 45 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 356 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2014 | 166 | 0.100 |
Why?
|
| Biliopancreatic Diversion | 1 | 2013 | 1 | 0.100 |
Why?
|
| Duodenum | 1 | 2013 | 5 | 0.100 |
Why?
|
| Choline | 1 | 2013 | 4 | 0.100 |
Why?
|
| Carbon | 1 | 2013 | 7 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2013 | 26 | 0.100 |
Why?
|
| Aging | 2 | 2018 | 1102 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 392 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 168 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 14 | 0.090 |
Why?
|
| Reference Values | 1 | 2012 | 169 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 37 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 75 | 0.090 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2011 | 1 | 0.090 |
Why?
|
| Ghrelin | 1 | 2011 | 2 | 0.090 |
Why?
|
| Neuropeptide Y | 1 | 2011 | 5 | 0.090 |
Why?
|
| Postoperative Care | 1 | 2012 | 107 | 0.090 |
Why?
|
| Diet, High-Fat | 1 | 2011 | 12 | 0.090 |
Why?
|
| Fasting | 1 | 2011 | 22 | 0.090 |
Why?
|
| Suture Techniques | 3 | 2007 | 112 | 0.090 |
Why?
|
| Food | 1 | 2011 | 30 | 0.090 |
Why?
|
| Chi-Square Distribution | 3 | 2007 | 124 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2012 | 284 | 0.090 |
Why?
|
| Cholecystectomy, Laparoscopic | 2 | 2015 | 20 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 232 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 3728 | 0.080 |
Why?
|
| Hospitals, University | 1 | 2009 | 22 | 0.080 |
Why?
|
| Medicaid | 1 | 2009 | 36 | 0.080 |
Why?
|
| Muscle, Smooth | 2 | 2006 | 12 | 0.080 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 17 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 104 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2007 | 24 | 0.060 |
Why?
|
| Vitamin D | 1 | 2007 | 27 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 26 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2007 | 51 | 0.060 |
Why?
|
| Surgical Instruments | 1 | 2006 | 24 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 137 | 0.060 |
Why?
|
| Tennessee | 1 | 2006 | 5 | 0.060 |
Why?
|
| Operative Time | 2 | 2017 | 82 | 0.060 |
Why?
|
| Markov Chains | 1 | 2006 | 30 | 0.060 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2006 | 17 | 0.060 |
Why?
|
| Gastroenterostomy | 1 | 2005 | 1 | 0.060 |
Why?
|
| Body Weight | 1 | 2006 | 129 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 34 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2006 | 78 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2006 | 39 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2005 | 34 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 107 | 0.060 |
Why?
|
| Endoscopy | 1 | 2007 | 166 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2006 | 61 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 256 | 0.060 |
Why?
|
| Equipment Design | 4 | 2006 | 120 | 0.060 |
Why?
|
| Diet | 1 | 2006 | 178 | 0.060 |
Why?
|
| Choledocholithiasis | 1 | 2004 | 1 | 0.060 |
Why?
|
| Cholecystolithiasis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Logistic Models | 1 | 2005 | 351 | 0.060 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2004 | 3 | 0.050 |
Why?
|
| COS Cells | 1 | 2004 | 38 | 0.050 |
Why?
|
| Cell Division | 1 | 2004 | 80 | 0.050 |
Why?
|
| Laryngostenosis | 1 | 2004 | 2 | 0.050 |
Why?
|
| Laryngitis | 1 | 2004 | 2 | 0.050 |
Why?
|
| Animals | 2 | 2018 | 3311 | 0.050 |
Why?
|
| Hyperthermia, Induced | 1 | 2004 | 4 | 0.050 |
Why?
|
| Motor Activity | 1 | 2006 | 267 | 0.050 |
Why?
|
| Calcium | 1 | 2007 | 369 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 244 | 0.050 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 3 | 0.050 |
Why?
|
| Bile | 2 | 1993 | 5 | 0.050 |
Why?
|
| Abdomen | 1 | 2022 | 7 | 0.050 |
Why?
|
| Pancreas | 1 | 2022 | 30 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2022 | 30 | 0.050 |
Why?
|
| Standard of Care | 1 | 2021 | 11 | 0.040 |
Why?
|
| Peritoneum | 1 | 2021 | 15 | 0.040 |
Why?
|
| Hydrocephalus | 1 | 2021 | 14 | 0.040 |
Why?
|
| Postmenopause | 1 | 2019 | 57 | 0.040 |
Why?
|
| Surgical Wound Infection | 2 | 2006 | 77 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 309 | 0.040 |
Why?
|
| Bone Development | 1 | 2018 | 29 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 13 | 0.030 |
Why?
|
| Anemia | 1 | 2017 | 30 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2006 | 286 | 0.030 |
Why?
|
| Colonic Pseudo-Obstruction | 1 | 1997 | 1 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 131 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 362 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 42 | 0.030 |
Why?
|
| Sigmoid Diseases | 1 | 1996 | 1 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 1996 | 2 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2017 | 147 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 387 | 0.030 |
Why?
|
| Abdominal Abscess | 1 | 1996 | 3 | 0.030 |
Why?
|
| Diverticulitis, Colonic | 1 | 1996 | 3 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 163 | 0.030 |
Why?
|
| Jejunum | 2 | 2006 | 10 | 0.030 |
Why?
|
| Diet Therapy | 1 | 2016 | 10 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 638 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 125 | 0.030 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 2 | 0.030 |
Why?
|
| Appendectomy | 1 | 2015 | 13 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 30 | 0.030 |
Why?
|
| Manometry | 2 | 2005 | 15 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 1993 | 47 | 0.020 |
Why?
|
| Conversion to Open Surgery | 1 | 2013 | 3 | 0.020 |
Why?
|
| Biopsy | 1 | 2013 | 189 | 0.020 |
Why?
|
| Esthetics | 1 | 2012 | 11 | 0.020 |
Why?
|
| Learning Curve | 1 | 2012 | 14 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1992 | 10 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 248 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 137 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 167 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 1990 | 25 | 0.020 |
Why?
|
| Computers | 1 | 1990 | 14 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2005 | 442 | 0.020 |
Why?
|
| Probability | 1 | 2007 | 71 | 0.020 |
Why?
|
| Gastric Acidity Determination | 1 | 2006 | 2 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 80 | 0.020 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2006 | 2 | 0.020 |
Why?
|
| Mesocolon | 1 | 2006 | 1 | 0.020 |
Why?
|
| Peritoneal Diseases | 1 | 2006 | 3 | 0.020 |
Why?
|
| Jejunal Diseases | 1 | 2006 | 3 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 6 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2006 | 8 | 0.020 |
Why?
|
| Pneumonia, Aspiration | 1 | 2006 | 7 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2006 | 87 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2006 | 12 | 0.020 |
Why?
|
| Needles | 1 | 2006 | 18 | 0.020 |
Why?
|
| Hernia | 1 | 2006 | 7 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2006 | 11 | 0.020 |
Why?
|
| Marital Status | 1 | 2006 | 9 | 0.020 |
Why?
|
| Energy Intake | 1 | 2006 | 77 | 0.020 |
Why?
|
| Peptide Hormones | 1 | 2006 | 3 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 318 | 0.010 |
Why?
|
| Thoracoscopy | 1 | 2005 | 22 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 30 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2005 | 56 | 0.010 |
Why?
|
| Neuromuscular Agents | 1 | 2005 | 3 | 0.010 |
Why?
|
| Esophageal Stenosis | 1 | 2005 | 3 | 0.010 |
Why?
|
| Botulinum Toxins | 1 | 2005 | 8 | 0.010 |
Why?
|
| Proton Pump Inhibitors | 1 | 2004 | 11 | 0.010 |
Why?
|
| Choledochostomy | 1 | 2004 | 1 | 0.010 |
Why?
|
| Common Bile Duct | 1 | 2004 | 1 | 0.010 |
Why?
|
| Cholangiography | 1 | 2004 | 7 | 0.010 |
Why?
|
| Gastroscopes | 1 | 2004 | 1 | 0.010 |
Why?
|
| Esophagoscopes | 1 | 2004 | 1 | 0.010 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2004 | 2 | 0.010 |
Why?
|
| Polyvinyls | 1 | 2004 | 3 | 0.010 |
Why?
|
| Polymethyl Methacrylate | 1 | 2004 | 10 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 113 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2004 | 65 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 801 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 592 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 373 | 0.010 |
Why?
|
| Endoscopy, Digestive System | 1 | 2003 | 7 | 0.010 |
Why?
|
| Gastrointestinal Transit | 1 | 2003 | 12 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 439 | 0.010 |
Why?
|
| Acute Disease | 2 | 1993 | 163 | 0.010 |
Why?
|
| Colostomy | 1 | 1996 | 2 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1996 | 27 | 0.010 |
Why?
|
| Drainage | 1 | 1996 | 36 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 1997 | 117 | 0.010 |
Why?
|
| Radiography | 1 | 1997 | 521 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1993 | 9 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1992 | 6 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 1992 | 6 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 1990 | 8 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1990 | 17 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1992 | 375 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1990 | 311 | 0.000 |
Why?
|